Zealand Pharma A/S (CPH:ZEAL)

Zealand Pharma Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,244	480.3	449.31	1,069	1,129	960.22
Short-Term Investments	-	23.63	-	-	-	-
Trading Asset Securities	9,334	7,722	1,184	108.61	299.04	297.35
Cash & Short-Term Investments	16,578	8,226	1,633	1,178	1,428	1,258
Cash Growth	85.58%	403.72%	38.65%	-17.53%	13.56%	-8.91%
Accounts Receivable	325.31	193.56	97.8	115.62	153.45	46.48
Other Receivables	101.42	97.44	40.99	21.6	21.56	15.44
Receivables	426.73	291	138.8	137.22	175.02	61.93
Inventory	10.3	10.7	7.94	1.29	118.44	65.04
Prepaid Expenses	-	-	-	-	-	35.16
Total Current Assets	17,015	8,528	1,780	1,316	1,722	1,420
Property, Plant & Equipment	134.16	125.25	149.85	165.49	221.45	213.04
Long-Term Investments	-	819.63	21.38	37.84	26.91	32.33
Other Intangible Assets	13.59	12.62	12.26	-	53.79	57.49
Long-Term Accounts Receivable	-	-	6.89	18.11	29.09	-
Long-Term Deferred Tax Assets	0.87	0.99	0.93	2.02	13.53	8.37
Other Long-Term Assets	16.54	19.41	8.91	-	1.27	31.04
Total Assets	17,180	9,506	1,980	1,540	2,068	1,762
Accounts Payable	312.27	181.28	91.61	180.76	266.39	70.38
Accrued Expenses	-	93.66	51.73	-	-	36.67
Current Portion of Leases	17.5	16.04	16.66	14.73	14.9	14.07
Current Income Taxes Payable	535.95	-	-	-	-	30.39
Current Unearned Revenue	153.88	-	-	-	53.03	53.18
Other Current Liabilities	107.84	112.5	124.59	-	-	150.56
Total Current Liabilities	1,127	403.47	284.58	195.49	334.32	355.26
Long-Term Debt	294	285.33	-	401.35	647.91	-
Long-Term Leases	85.46	90.39	102.58	108	124.63	116.05
Long-Term Unearned Revenue	12.61	-	-	-	14.55	44.59
Other Long-Term Liabilities	51.77	109.67	-	19.06	18.43	16.74
Total Liabilities	1,571	888.86	387.15	723.9	1,140	532.64
Common Stock	71.34	71.02	58.75	51.7	43.63	39.8
Additional Paid-In Capital	14,711	14,681	6,406	4,921	-	3,472
Retained Earnings	803.23	-6,157	-4,895	-4,172	-	-2,290
Treasury Stock	-	-	-	-	-	-1.7
Comprehensive Income & Other	23.14	22.39	22.7	14.62	884.17	8.98
Shareholders' Equity	15,609	8,617	1,593	815.91	927.8	1,229
Total Liabilities & Equity	17,180	9,506	1,980	1,540	2,068	1,762
Total Debt	396.95	391.76	119.23	524.08	787.43	130.12
Net Cash (Debt)	16,181	8,654	1,514	653.77	640.72	1,127
Net Cash Growth	72.92%	471.66%	131.55%	2.04%	-43.17%	-12.92%
Net Cash Per Share	226.89	130.26	26.75	14.15	14.95	29.38
Filing Date Shares Outstanding	70.73	70.65	58.38	51.47	43.22	39.55
Total Common Shares Outstanding	70.73	70.65	58.38	51.47	43.22	39.74
Working Capital	15,887	8,124	1,495	1,121	1,387	1,064
Book Value Per Share	220.68	121.96	27.28	15.85	21.47	30.94
Tangible Book Value	15,595	8,604	1,581	815.91	874.01	1,172
Tangible Book Value Per Share	220.49	121.78	27.07	15.85	20.22	29.49
Buildings	-	-	-	-	-	34.1
Machinery	-	84.91	78.57	82.83	106.63	101.18
Construction In Progress	-	-	-	0.87	12.11	3.02
Leasehold Improvements	-	39.3	38.91	38.19	36.6	-

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.